Eurofins: finalises acquisition of Transplant Genomics
(CercleFinance.com) - Eurofins Scientific has said that it has completed the acquisition of Transplant Genomics, a molecular diagnostics company dedicated to improving the outcome of organ transplants by using genomics.
Eurofins did not reveal the financial terms of the deal.
The group said, “TGI's innovative non-invasive tests for the management of patients with silent inflammation and rejection following kidney transplants will strengthen and complement Eurofins' industry leading global Transplant Diagnostics offering, which includes VRL, Inc.... and Viracor, Inc. in the U.S.”
Copyright (c) 2019 CercleFinance.com. All rights reserved.
Eurofins did not reveal the financial terms of the deal.
The group said, “TGI's innovative non-invasive tests for the management of patients with silent inflammation and rejection following kidney transplants will strengthen and complement Eurofins' industry leading global Transplant Diagnostics offering, which includes VRL, Inc.... and Viracor, Inc. in the U.S.”
Copyright (c) 2019 CercleFinance.com. All rights reserved.